Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aluminium monostearate is an organic compound that is the aluminum salt of stearic acid. It has the molecular formula Al(OH)2C18H35O2 and is also known as dihydroxyaluminium or dihydroxy(stearato)aluminium. In the pharmaceutical industry, it is primarily used as an excipient—serving as an anticaking agent, colorant, emulsion stabilizer, and viscosity-increasing agent. It forms gels for packaging pharmaceuticals and in cosmetic preparations. While generally considered safe for use in food and pharmaceuticals by regulatory agencies such as the FDA, excessive exposure may lead to accumulation of aluminum in the body[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aluminium monostearate.